Jobst Greeve

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus
    Marianne Bonvin
    Department of Clinical Research, Switzerland, University of Berne, Berne, Switzerland
    Curr Opin Infect Dis 21:298-303. 2008
  2. ncbi Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
    Jobst Greeve
    Zentrum fur Innere Medizin, Medizinische Klinik I, Universitatsklinikum Hamburg Eppendorf, Germany
    Blood 101:3574-80. 2003
  3. ncbi Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits
    Frank Apostel
    Klinik und Poliklinik für Innere Medizin, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, Germany
    Biochim Biophys Acta 1577:384-94. 2002
  4. ncbi Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker
    Heinrich Lellek
    , Kernklinik und Poliklinik, , Martinistrasse 52, 20246 Hamburg, Germany
    J Biol Chem 277:23638-44. 2002
  5. ncbi The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system
    Kristina Krause
    Department of Clinical Research, University of Berne, Berne, Switzerland
    Mol Immunol 43:295-307. 2006
  6. ncbi Gene structure and expression of the mouse APOBEC-1 complementation factor: multiple transcriptional initiation sites and a spliced variant with a premature stop translation codon
    Stefan Dür
    Department of General Internal Medicine, Inselspital University Hospital Bern, CH 3010 Bern, Switzerland
    Biochim Biophys Acta 1680:11-23. 2004
  7. ncbi Authors reply to I.B. Rogozin and Y.I. Pavlov: 'The cytidine deaminase AID exhibits similar functional properties in yeast and mammals'
    Kristina Krause
    Mol Immunol 43:1924-6. 2006
  8. ncbi Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
    Marianne Bonvin
    Department of Clinical Research, University Hospital Berne, Switzerland
    Hepatology 43:1364-74. 2006
  9. ncbi Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro
    Marianne Bonvin
    Department of Clinical Research, University Hospital Berne, Switzerland
    J Gen Virol 88:3270-4. 2007

Collaborators

  • Reinhard Dammann
  • W Klapper
  • Marianne Bonvin
  • Kristina Krause
  • Kenneth B Marcu
  • Stefan Dür
  • Frank Apostel
  • Heinrich Lellek
  • Simon Wain-Hobson
  • Jean-Pierre Vartanian
  • Daniel Inderbitzin
  • Adrian Keogh
  • Peter Sommer
  • Isabell Greeve
  • Daniel Candinas
  • Deborah Stroka
  • Nina Pluntke
  • Sybille Welker
  • Romy Kirsten
  • Gerd P Pfeifer
  • Ines Diehl

Detail Information

Publications9

  1. ncbi Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus
    Marianne Bonvin
    Department of Clinical Research, Switzerland, University of Berne, Berne, Switzerland
    Curr Opin Infect Dis 21:298-303. 2008
    ..This review focuses on the effects of APOBEC3 enzymes on the pararetrovirus hepatitis B virus...
  2. ncbi Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
    Jobst Greeve
    Zentrum fur Innere Medizin, Medizinische Klinik I, Universitatsklinikum Hamburg Eppendorf, Germany
    Blood 101:3574-80. 2003
    ..This constitutive expression of AID may promote illegitimate DNA recombinations and somatic mutations in B-NHL...
  3. ncbi Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits
    Frank Apostel
    Klinik und Poliklinik für Innere Medizin, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, Germany
    Biochim Biophys Acta 1577:384-94. 2002
    ..Thus, the weak proximal rat APOBEC-1 promoter appears to be down-regulated in the rabbit and may be species-specific...
  4. ncbi Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker
    Heinrich Lellek
    , Kernklinik und Poliklinik, , Martinistrasse 52, 20246 Hamburg, Germany
    J Biol Chem 277:23638-44. 2002
    ..The Gal4-Gal80 system is analogous to the two-hybrid assay and may have broader applications for the study of other mRNA processing reactions...
  5. ncbi The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system
    Kristina Krause
    Department of Clinical Research, University of Berne, Berne, Switzerland
    Mol Immunol 43:295-307. 2006
    ..In contrast to APOBEC-1, AID alone does not exhibit an intrinsic specificity for its target sequences...
  6. ncbi Gene structure and expression of the mouse APOBEC-1 complementation factor: multiple transcriptional initiation sites and a spliced variant with a premature stop translation codon
    Stefan Dür
    Department of General Internal Medicine, Inselspital University Hospital Bern, CH 3010 Bern, Switzerland
    Biochim Biophys Acta 1680:11-23. 2004
    ....
  7. ncbi Authors reply to I.B. Rogozin and Y.I. Pavlov: 'The cytidine deaminase AID exhibits similar functional properties in yeast and mammals'
    Kristina Krause
    Mol Immunol 43:1924-6. 2006
  8. ncbi Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
    Marianne Bonvin
    Department of Clinical Research, University Hospital Berne, Switzerland
    Hepatology 43:1364-74. 2006
    ..In conclusion, the editing enzymes A3B(L), A3F, and most markedly A3G, which are expressed in liver and up-regulated by IFN-alpha in hepatocytes, are candidates to contribute to the noncytolytic clearance of HBV...
  9. ncbi Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro
    Marianne Bonvin
    Department of Clinical Research, University Hospital Berne, Switzerland
    J Gen Virol 88:3270-4. 2007
    ....